DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Palovarotene
Palovarotene
Horizon Scanning Status Report June 2019
Annexes to the Annual Report of the European Medicines Agency 2014
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
2016 Medicines in Development for Rare Diseases a LIST of ORPHAN DRUGS in the PIPELINE
JULY 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
2018 年全球新药研发报告——第2 部分: 趋势与挑战(Ⅴ) Areport Of
Der Einfluss Der VO (EG) 1901/2006 Auf Den Off-Label Use in Der Neonatologie“
WHO Drug Information Vol
Stembook 2018.Pdf
Horizon Scanning Status Report December 2020
OCTOBER 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Rxoutlook® 3Rd Quarter 2020
Congreso Latinoamericano De Glicobiología
High Potential Disruption Report May 2020
Concomitant Extraspinal Hyperostosis and Osteoporosis in a Patient with Congenital Ichthyosis
Orphan Drug Designation List
Medicines Not Reimbursed Through National Prices and Directly Commissioned by Nhs England
2015 Symposium Booklet
Top View
Pharmacology and Toxicology
FOP) Collaborative Research Project
Brand Pipeline Forecast 4Th Quarter 2019
Changelog (In Alphabetical Order of the Value Set) Value Set Code Description Change
Annexes to the Annual Report of the European Medicines Agency 2018
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
WHO Drug Information Contents
Drug Repurposing Compound Library Plus (96-Well)
ATC Vet 2021 Atccode Atcdescription Atcdescriptionsi QA ALIMENTARY TRACT and METABOLISM ZDRAVILA ZA BOLEZNI PREBAVIL in PRESNOVE
2020 Medicines in Development for Children
Trifarotene: a Current Review and Perspectives in Dermatology
From Innovation to Patient Solution
Drug Repurposing Compound Library (96-Well)
Advances and Challenges in Retinoid Delivery Systems in Regenerative
Administration of a Selective Retinoic Acid Receptor-Γ Agonist Improves Neuromuscular Strength in a Rodent Model of Volumetric Muscle Loss Michael E
The Evolving Therapeutic Landscape of Genetic Skeletal Disorders Ataf Hussain Sabir* and Trevor Cole
A View Into Upcoming Specialty and Traditional Drugs JANUARY 2019
Annexes to the Annual Report of the European Medicines Agency 2020
Fda's Rocket Docket
Palovarotene Reduces Heterotopic Ossification in Juvenile FOP Mice
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016
Generic Pipeline Forecast This Section Provides a Summary of Upcoming First-Time Generic Drugs and Biosimilars That May Be Approved in the Upcoming Two Years